Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Renal Drug Excretion: Overview01:15

Renal Drug Excretion: Overview

As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The evolving field of nephrology: what comes next? A report from the European Renal Association Scientific Advisory Board.

Clinical kidney journal·2026
Same author

Natural Language Processing of Unstructured Healthcare Data for Predicting Heart Failure in Individuals with Type 2 Diabetes.

Journal of clinical medicine·2026
Same author

Systemic inflammatory profiles are associated with long-term kidney failure and patient mortality in chronic kidney disease.

Clinical kidney journal·2026
Same author

Endogenous α-Klotho is a common target in atherosclerosis and calcific aortic valve disease.

Biochemical pharmacology·2026
Same author

Inflammatory markers associated with albuminuria and early atherosclerosis in type 2 diabetic kidney disease: a cross-sectional study.

Frontiers in endocrinology·2026
Same author

Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data.

Kidney diseases (Basel, Switzerland)·2026

Related Experiment Video

Updated: May 12, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

ENaC modulators and renal disease.

Diego Alvarez de la Rosa1, Juan F Navarro-González, Teresa Giraldez

  • 1Department of Physiology, Universidad de La Laguna and Instituto de Tecnologías Biomédicas, La Laguna, Tenerife, Spain. diego.alvarez@ull.es

Current Molecular Pharmacology
|April 4, 2013
PubMed
Summary
This summary is machine-generated.

The epithelial sodium channel (ENaC) is crucial for regulating blood pressure by controlling sodium reabsorption. This review covers ENaC regulation, compounds affecting it, and clinical uses of ENaC and aldosterone antagonists.

More Related Videos

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

Related Experiment Videos

Last Updated: May 12, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Physiology

Background:

  • The epithelial sodium channel (ENaC) is vital for sodium reabsorption in the kidneys, impacting electrolyte balance, extracellular volume, and blood pressure.
  • Aldosterone is a key steroid hormone that enhances ENaC activity, playing a significant role in physiological regulation.

Purpose of the Study:

  • To review current knowledge on the regulation of the epithelial sodium channel (ENaC).
  • To discuss chemical compounds that modulate ENaC function.
  • To highlight clinical applications of ENaC and aldosterone antagonists.

Main Methods:

  • Literature review of scientific publications on ENaC.
  • Analysis of signaling pathways converging on ENaC.
  • Summary of pharmacological agents targeting ENaC and aldosterone pathways.

Main Results:

  • ENaC regulation involves multiple signaling pathways, with aldosterone being a primary modulator.
  • Various chemical compounds can directly or indirectly influence ENaC activity.
  • ENaC and aldosterone antagonists have established and potential clinical uses.

Conclusions:

  • Understanding ENaC regulation is key for managing blood pressure and fluid balance.
  • Pharmacological targeting of ENaC offers therapeutic potential.
  • Aldosterone antagonists are important in treating conditions related to sodium retention.